Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 11, 2014
STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinomaQu Zhang, Chi Zhang, Jia He, et al.
Theranostics|November 8, 2017
Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-αXiao-Wei Dou, Yuan-Ke Liang, Hao-Yu Lin, et al.
Frontiers in Oncology|July 12, 2021
Mutant p53 and Twist1 Co-Expression Predicts Poor Prognosis and Is an Independent Prognostic Factor in Breast CancerYong-Qu Zhang, Fan Zhang, Yun-Zhu Zeng, et al.
NPJ Breast Cancer|August 16, 2018
MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell linesYuan-Ke Liang, Hao-Yu Lin, Xiao-Wei Dou, et al.
Genome Biology and Evolution|December 6, 2018
The Transcriptomic Landscape of Yaks Reveals Molecular Pathways for High Altitude AdaptationXuebin Qi, Qu Zhang, Yaoxi He, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2021
Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody-Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or EnzalutamideJohann S de Bono, Mark T Fleming, Judy S Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2025
Mutational Landscape of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Association with Immune Checkpoint Inhibitor OutcomesPatricia McCoon, Ying Wang, Zhongwu Lai, et al.
Cancer Discovery|August 21, 2020
Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint BlockadeQu Zhang, Jia Luo, Song Wu, et al.
Medcomm|October 26, 2023
Methylation of ESR1 promoter induced by SNAI2-DNMT3B complex promotes epithelial-mesenchymal transition and correlates with poor prognosis in ERα-positive breast cancersJi-Wei Li, Qiu-Min Deng, Jian-Ling Zhu, et al.
Blood|December 13, 2017
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphomaAlex F Herrera, Alison J Moskowitz, Nancy L Bartlett, et al.
Pageof 12